Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccine
Soluble tumor-associated antigens have antitumor effect on mammary tumors
February 17th, 2005
Vaccination with human soluble tumor-associated antigens exerted an antitumor effect on mammary tumors in rats. According to recent research published in the journal Oncology Reports, "We showed previously that soluble tumor-associated antigens (sTAA) isolated from breast cancer patients could suppress chemically-induced tumorigenesis in rats in comparison to the effect of commercial human albumin (CHA). Herein we analyze the possible mechanism of those findings. The following groups of mammary tumor-bearing rats were used in the studies: control rats treated with saline; rats treated with CHA; and rats treated with human sTAA. Different zones of the spleen,...
Source: Women's Health Weekly (2005-02-17)
|
